Published • loading... • Updated
Pharmaceutical Group Submits EU Complaint Against GKV-Spargesetz
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Berlin – The pharmaceutical group AbbVie lodges a complaint with the European Union against the GKV contribution rate stabilization law (BStabG). The European Commission is therefore to examine whether cross-active discount agreements for patent-protected medicinal products violate EU state aid law. These are the so-called focus lists,...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
